866-997-4948(US-Canada Toll Free)

United States Dermatological Therapeutics Market Report 2018

Published By :

QYResearch

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 101 Pages

In this report, the United States Dermatological Therapeutics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Dermatological Therapeutics in these regions, from 2013 to 2025 (forecast).

United States Dermatological Therapeutics market competition by top manufacturers/players, with Dermatological Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
AGI Dermatics
Allergan
Amgen
Chester Valley
Dermik
Eisai
Ferndale
Genentech
Medicis
Onset Therapeutics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Anti-infectives
Corticosteroids
Anti Psoriasis
Anti-acne
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic

Table of Contents

United States Dermatological Therapeutics Market Report 2018
1 Dermatological Therapeutics Overview
1.1 Product Overview and Scope of Dermatological Therapeutics
1.2 Classification of Dermatological Therapeutics by Product Category
1.2.1 United States Dermatological Therapeutics Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Dermatological Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Anti-infectives
1.2.4 Corticosteroids
1.2.5 Anti Psoriasis
1.2.6 Anti-acne
1.2.7 Others
1.3 United States Dermatological Therapeutics Market by Application/End Users
1.3.1 United States Dermatological Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.4 United States Dermatological Therapeutics Market by Region
1.4.1 United States Dermatological Therapeutics Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Dermatological Therapeutics Status and Prospect (2013-2025)
1.4.3 Southwest Dermatological Therapeutics Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Dermatological Therapeutics Status and Prospect (2013-2025)
1.4.5 New England Dermatological Therapeutics Status and Prospect (2013-2025)
1.4.6 The South Dermatological Therapeutics Status and Prospect (2013-2025)
1.4.7 The Midwest Dermatological Therapeutics Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Dermatological Therapeutics (2013-2025)
1.5.1 United States Dermatological Therapeutics Sales and Growth Rate (2013-2025)
1.5.2 United States Dermatological Therapeutics Revenue and Growth Rate (2013-2025)

2 United States Dermatological Therapeutics Market Competition by Players/Suppliers
2.1 United States Dermatological Therapeutics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Dermatological Therapeutics Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Dermatological Therapeutics Average Price by Players/Suppliers (2013-2018)
2.4 United States Dermatological Therapeutics Market Competitive Situation and Trends
2.4.1 United States Dermatological Therapeutics Market Concentration Rate
2.4.2 United States Dermatological Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Dermatological Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 United States Dermatological Therapeutics Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Dermatological Therapeutics Sales and Market Share by Region (2013-2018)
3.2 United States Dermatological Therapeutics Revenue and Market Share by Region (2013-2018)
3.3 United States Dermatological Therapeutics Price by Region (2013-2018)

4 United States Dermatological Therapeutics Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Dermatological Therapeutics Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Dermatological Therapeutics Revenue and Market Share by Type (2013-2018)
4.3 United States Dermatological Therapeutics Price by Type (2013-2018)
4.4 United States Dermatological Therapeutics Sales Growth Rate by Type (2013-2018)

5 United States Dermatological Therapeutics Sales (Volume) by Application (2013-2018)
5.1 United States Dermatological Therapeutics Sales and Market Share by Application (2013-2018)
5.2 United States Dermatological Therapeutics Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States Dermatological Therapeutics Players/Suppliers Profiles and Sales Data
6.1 AGI Dermatics
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Dermatological Therapeutics Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AGI Dermatics Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Allergan
6.2.2 Dermatological Therapeutics Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Allergan Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Amgen
6.3.2 Dermatological Therapeutics Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Amgen Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Chester Valley
6.4.2 Dermatological Therapeutics Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Chester Valley Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Dermik
6.5.2 Dermatological Therapeutics Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Dermik Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Eisai
6.6.2 Dermatological Therapeutics Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Eisai Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Ferndale
6.7.2 Dermatological Therapeutics Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Ferndale Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Genentech
6.8.2 Dermatological Therapeutics Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Genentech Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Medicis
6.9.2 Dermatological Therapeutics Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Medicis Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Onset Therapeutics
6.10.2 Dermatological Therapeutics Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Onset Therapeutics Dermatological Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview

7 Dermatological Therapeutics Manufacturing Cost Analysis
7.1 Dermatological Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dermatological Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Dermatological Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dermatological Therapeutics Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Dermatological Therapeutics Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Dermatological Therapeutics Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Dermatological Therapeutics Sales Volume Forecast by Type (2018-2025)
11.3 United States Dermatological Therapeutics Sales Volume Forecast by Application (2018-2025)
11.4 United States Dermatological Therapeutics Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Dermatological Therapeutics
Figure United States Dermatological Therapeutics Market Size (K Units) by Type (2013-2025)
Figure United States Dermatological Therapeutics Sales Volume Market Share by Type (Product Category) in 2017
Figure Anti-infectives Product Picture
Figure Corticosteroids Product Picture
Figure Anti Psoriasis Product Picture
Figure Anti-acne Product Picture
Figure Others Product Picture
Figure United States Dermatological Therapeutics Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Dermatological Therapeutics by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure United States Dermatological Therapeutics Market Size (Million USD) by Region (2013-2025)
Figure The West Dermatological Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Dermatological Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Dermatological Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Dermatological Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Dermatological Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Dermatological Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Dermatological Therapeutics Sales (K Units) and Growth Rate (2013-2025)
Figure United States Dermatological Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Dermatological Therapeutics Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Dermatological Therapeutics Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Dermatological Therapeutics Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Dermatological Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Dermatological Therapeutics Sales Share by Players/Suppliers
Figure United States Dermatological Therapeutics Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Dermatological Therapeutics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Dermatological Therapeutics Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Dermatological Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Dermatological Therapeutics Revenue Share by Players/Suppliers
Table United States Market Dermatological Therapeutics Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Dermatological Therapeutics Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Dermatological Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Dermatological Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Dermatological Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Dermatological Therapeutics Product Category
Table United States Dermatological Therapeutics Sales (K Units) by Region (2013-2018)
Table United States Dermatological Therapeutics Sales Share by Region (2013-2018)
Figure United States Dermatological Therapeutics Sales Share by Region (2013-2018)
Figure United States Dermatological Therapeutics Sales Market Share by Region in 2017
Table United States Dermatological Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Dermatological Therapeutics Revenue Share by Region (2013-2018)
Figure United States Dermatological Therapeutics Revenue Market Share by Region (2013-2018)
Figure United States Dermatological Therapeutics Revenue Market Share by Region in 2017
Table United States Dermatological Therapeutics Price (USD/Unit) by Region (2013-2018)
Table United States Dermatological Therapeutics Sales (K Units) by Type (2013-2018)
Table United States Dermatological Therapeutics Sales Share by Type (2013-2018)
Figure United States Dermatological Therapeutics Sales Share by Type (2013-2018)
Figure United States Dermatological Therapeutics Sales Market Share by Type in 2017
Table United States Dermatological Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Dermatological Therapeutics Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Dermatological Therapeutics by Type (2013-2018)
Figure Revenue Market Share of Dermatological Therapeutics by Type in 2017
Table United States Dermatological Therapeutics Price (USD/Unit) by Types (2013-2018)
Figure United States Dermatological Therapeutics Sales Growth Rate by Type (2013-2018)
Table United States Dermatological Therapeutics Sales (K Units) by Application (2013-2018)
Table United States Dermatological Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Dermatological Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Dermatological Therapeutics Sales Market Share by Application in 2017
Table United States Dermatological Therapeutics Sales Growth Rate by Application (2013-2018)
Figure United States Dermatological Therapeutics Sales Growth Rate by Application (2013-2018)
Table AGI Dermatics Basic Information List
Table AGI Dermatics Dermatological Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AGI Dermatics Dermatological Therapeutics Sales Growth Rate (2013-2018)
Figure AGI Dermatics Dermatological Therapeutics Sales Market Share in United States (2013-2018)
Figure AGI Dermatics Dermatological Therapeutics Revenue Market Share in United States (2013-2018)
Table Allergan Basic Information List
Table Allergan Dermatological Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Allergan Dermatological Therapeutics Sales Growth Rate (2013-2018)
Figure Allergan Dermatological Therapeutics Sales Market Share in United States (2013-2018)
Figure Allergan Dermatological Therapeutics Revenue Market Share in United States (2013-2018)
Table Amgen Basic Information List
Table Amgen Dermatological Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Dermatological Therapeutics Sales Growth Rate (2013-2018)
Figure Amgen Dermatological Therapeutics Sales Market Share in United States (2013-2018)
Figure Amgen Dermatological Therapeutics Revenue Market Share in United States (2013-2018)
Table Chester Valley Basic Information List
Table Chester Valley Dermatological Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Chester Valley Dermatological Therapeutics Sales Growth Rate (2013-2018)
Figure Chester Valley Dermatological Therapeutics Sales Market Share in United States (2013-2018)
Figure Chester Valley Dermatological Therapeutics Revenue Market Share in United States (2013-2018)
Table Dermik Basic Information List
Table Dermik Dermatological Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Dermik Dermatological Therapeutics Sales Growth Rate (2013-2018)
Figure Dermik Dermatological Therapeutics Sales Market Share in United States (2013-2018)
Figure Dermik Dermatological Therapeutics Revenue Market Share in United States (2013-2018)
Table Eisai Basic Information List
Table Eisai Dermatological Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eisai Dermatological Therapeutics Sales Growth Rate (2013-2018)
Figure Eisai Dermatological Therapeutics Sales Market Share in United States (2013-2018)
Figure Eisai Dermatological Therapeutics Revenue Market Share in United States (2013-2018)
Table Ferndale Basic Information List
Table Ferndale Dermatological Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Ferndale Dermatological Therapeutics Sales Growth Rate (2013-2018)
Figure Ferndale Dermatological Therapeutics Sales Market Share in United States (2013-2018)
Figure Ferndale Dermatological Therapeutics Revenue Market Share in United States (2013-2018)
Table Genentech Basic Information List
Table Genentech Dermatological Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Genentech Dermatological Therapeutics Sales Growth Rate (2013-2018)
Figure Genentech Dermatological Therapeutics Sales Market Share in United States (2013-2018)
Figure Genentech Dermatological Therapeutics Revenue Market Share in United States (2013-2018)
Table Medicis Basic Information List
Table Medicis Dermatological Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Medicis Dermatological Therapeutics Sales Growth Rate (2013-2018)
Figure Medicis Dermatological Therapeutics Sales Market Share in United States (2013-2018)
Figure Medicis Dermatological Therapeutics Revenue Market Share in United States (2013-2018)
Table Onset Therapeutics Basic Information List
Table Onset Therapeutics Dermatological Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Onset Therapeutics Dermatological Therapeutics Sales Growth Rate (2013-2018)
Figure Onset Therapeutics Dermatological Therapeutics Sales Market Share in United States (2013-2018)
Figure Onset Therapeutics Dermatological Therapeutics Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dermatological Therapeutics
Figure Manufacturing Process Analysis of Dermatological Therapeutics
Figure Dermatological Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Dermatological Therapeutics Major Players/Suppliers in 2017
Table Major Buyers of Dermatological Therapeutics
Table Distributors/Traders List
Figure United States Dermatological Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Dermatological Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Dermatological Therapeutics Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Dermatological Therapeutics Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Dermatological Therapeutics Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Dermatological Therapeutics Sales Volume (K Units) Forecast by Type in 2025
Table United States Dermatological Therapeutics Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Dermatological Therapeutics Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Dermatological Therapeutics Sales Volume (K Units) Forecast by Application in 2025
Table United States Dermatological Therapeutics Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Dermatological Therapeutics Sales Volume Share Forecast by Region (2018-2025)
Figure United States Dermatological Therapeutics Sales Volume Share Forecast by Region (2018-2025)
Figure United States Dermatological Therapeutics Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *